
|Articles|May 1, 2001
- Pharmaceutical Executive-05-01-2001
The Regulatory Environment
Rules imposed by FDA and other regulatory agencies add legal challenges to promoting pharmaceuticals.
Advertisement
Articles in this issue
about 25 years ago
The Power of Public Relationsabout 25 years ago
Market Research 101about 25 years ago
World-Class Marketing Plansabout 25 years ago
How to Win Friends and Influence R&Dabout 25 years ago
Working with an Agencyabout 25 years ago
A Strategic OverviewAdvertisement
Advertisement
Advertisement
Trending on PharmExec
1
Why High-Risk Patients Still Need Antivirals: Q&A with Gurinder S. Sidhu, M.D.
2
How Exposed is The U.S. Pharmaceutical Supply Chain to China’s Updated Export Control Regulations?
3
A Patent Strategy Pharma Execs May Be Overlooking: Means-Plus-Function Claims
4
Pharmaceutical Executive Daily: Bristol Myers Squibb Expands Partnership with Nvidia
5




